---
title: "Atraverse closes US$29 million to boost commercialisation of Hotwire transseptal access technology"
date: "2025-06-13T15:17:41.000Z"
publishedDate: "13 juin 2025"
summary: "Atraverse Medical has announced the close of US$29.4 million in follow-on financing to accelerate growth, building upon the US$12.5 million in prior seed investment that was previously used to obtain US Food and Drug Administration (FDA) 510(k) clearance and begin early commercialisation of Hotwire—the company&#8217;s novel radiofrequency (RF) guidewire for left-heart access. Designed to simplify [&#8230;] The post Atraverse closes US$29 million to boost commercialisation of Hotwire transseptal access technology appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/atraverse-closes-us29-million-to-boost-commercialisation-of-hotwire-transseptal-access-technology/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-06-13-atraverse-closes-usdollar29-million-to-boost-commercialisation-of-hotwire-transseptal-access-technology"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/06/Atraverse-logo-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/atraverse-closes-us29-million-to-boost-commercialisation-of-hotwire-transseptal-access-technology/"
---

![Atraverse closes US$29 million to boost commercialisation of Hotwire transseptal access technology](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/06/Atraverse-logo-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/atraverse-closes-us29-million-to-boost-commercialisation-of-hotwire-transseptal-access-technology/*

## L’essentiel

Atraverse Medical has announced the close of US$29.4 million in follow-on financing to accelerate growth, building upon the US$12.5 million in prior seed investment that was previously used to obtain US Food and Drug Administration (FDA) 510(k) clearance and begin early commercialisation of Hotwire—the company&#8217;s novel radiofrequency (RF) guidewire for left-heart access. Designed to simplify [&#8230;] The post Atraverse closes US$29 million to boost commercialisation of Hotwire transseptal access technology appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/atraverse-closes-us29-million-to-boost-commercialisation-of-hotwire-transseptal-access-technology/
